Altenburger advised Ensemble Hospitalier de la Côte (EHC) – a healthcare network encompassing 36 medical centers throughout Switzerland – on its acquisition of Niedol Center, a Renens-based specialist in dialysis. The Altenburger team Partner Manuel Moor (corporate/
Tags :sx3
Walder Wyss advised Groupe E on a CHF 250m bond issuance. The transaction encompasses a CHF 100m 4-year tranche with a fixed coupon of 0.750% and a CHF 150m 10-year tranche with a fixed coupon
Vischer advised Proteomedix, a Swiss biotech subsidiary of Onconetix, on a licensing agreement with Swedish pancreatic cancer diagnostics company Immunovia. The agreement Under the terms of the agreement, Proteomedix will supply Immunovia with master
Kellerhals Carrard advised Swiss ERP software specialist Garaio Rem throughout the acquisition of a stake in imofix.io. The parties Headquartered in Bern, Garaio Rem is a provider of ERP software for real estate management.
Kellerhals Carrard advised Swiss Automotive Group’s majority owner Sandro Piffaretti, as the company gained an anchor shareholder in a Swiss entrepreneurial family office. The Kellerhals Carrard team The Kellerhals Carrard team working on the
Schellenberg Wittmer advised OC Oerlikon as the Freienbach-based surface technologies specialist placed CHF 350 million in dual-tranche senior unsecured bonds. The placement The operation features two tranches, respectively of CHF 150 million 1.375% bonds due in 2028 and CHF 200
Zurich-based Thouvenin advised Global Group on the acquisition of Swiss Quality Broker, an insurance broker with headquarters in Pfaffikon and active across the country. The Thouvenin team The Thouvenin lineup working on the matter included
Abacus Medicine Group – a Danish group active across the modern healthcare sector – completed the acquisition of Swiss Cardio Technologies. In connection the deal Shellenberg Wittmer advised the buyer, while Baker McKenzie Switzerland represented the shareholders
Advestra advised Glencore, CPP Investments and British Columbia Investment Management Corporation, all shareholders of Viterra Limited, on the merger with Bunge Global. The operation in question led to the creation of a global agribusiness
Advestra advised life sciences startup EvlaBio on its EUR 21 million seed financing round. Headquartered in Zurich, EvlaBio specialises in the development of therapies for Left Ventricular Hypertrophy (LVH) in the context of Chronic Kidney Disease (
